Approximately 200,000 men are diagnosed with prostate cancer each year and about 30,000 will die of their disease, according to the CDC.
Options including surgery, chemotherapy and radiation can be overwhelming, so how do you choose the right treatment for you? One man found hope after receiving a bleak prognosis.
Prostate cancer is the most common non-skin cancer in men today. It surpasses even the number of breast cancer cases diagnosed in women. Now, a non-invasive targeted therapy developed and offered in Sarasota is helping doctors pinpoint the smallest and most difficult to reach tumors with radiation.
When Bruce Scott was diagnosed with prostate cancer, he was told that he had only six to eighteen months to live. That was more than five years ago.
He sought the help of Dr. Michael Dattoli of Dattoli Cancer Center, who customized a plan involving brachytherapy and DART or Dynamic Adaptive Radiation Therapy. DART is a non-invasive treatment that hones in on the tumor while sparing the surrounding healthy tissue. "Your particular plan, your particular map, if you will, for where these beams go is made just for you, and then that map is programmed into a computer," says Scott.
DART technology not only pinpoints the tumor, but stays focused on the target even when it moves within the body.
Scott says there was no pain associated with the actual radiation treatment, and that other than a loss of appetite and some fatigue from the medication there were minimal side effects.
He says that based upon his original diagnosis he wouldn’t be here. His most recent check-up at Dattoli finds him cancer free, and we wish him well.